Sung Lee - 31 May 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: EVP, Chief Financial Officer
Signature: /s/ John O. Faurescu, attorney-in-fact for Mr. Lee
Issuer symbol: CYTK
Transactions as of: 31 May 2024
Net transactions value: $0
Form type: 4
Filing time: 03 Jun 2024, 17:07:36 UTC
Previous filing: 30 Apr 2024
Next filing: 05 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Award	$0	+34,684		$0.000000	34,684	31 May 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Award	$0	+53,417		$0.000000	53,417	31 May 2024	Common Stock	53,417	$48.51	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Comprised of restricted stock units convertible into shares of common stock on a 1-for-1 basis and vesting as follows: 40% on the 1-year anniversary of the grant date, an additional 40% on the 2-year anniversary of the grant date, and the remaining 20% on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment.
F2	Comprised of non-statutory stock options to purchase shares of common stock and vesting as follows: 25% on the 1-year anniversary of the grant date and the remaining 75% vesting in equal monthly installments over the subsequent 36 months from the 1-year anniversary of the grant date, in each case subject to continued employment.